These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 579063)

  • 1. The pharmacology of a new potent, long acting neuroleptic, piflutixol.
    Nielsen IM; Boeck V; Christensen AV; Danneskiold-Samsoe P; Hyttel J; Langeland J; Pedersen V; Svendsen O
    Acta Pharmacol Toxicol (Copenh); 1977 Oct; 41(4):369-83. PubMed ID: 579063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
    Christensen AV; Arnt J; Hyttel J; Svendsen O
    Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of neuroleptics upon repeated administration.
    Moller Nielsen I; Fjalland B; Pedersen V; Nymark M
    Psychopharmacologia; 1974 Jan; 34(2):95-104. PubMed ID: 4856370
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of piflutixol on turnover of catecholamines in mouse brain and rat corpus striatum.
    Hyttel J
    Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):449-57. PubMed ID: 579556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of cis(Z)-clopenthixol decanoate, a depot neuroleptic.
    Pedersen V; Svendsen O; Danneskiold-Samsoe P; Boeck V; Nielsen IM
    Acta Pharmacol Toxicol (Copenh); 1977 Apr; 40(4):482-90. PubMed ID: 577108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.
    Voith K; Herr F
    Psychopharmacologia; 1975 Apr; 42(1):11-20. PubMed ID: 1171496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between the occupation of the D-1 dopamine receptor by [3H]piflutixol and the activity of dopamine-sensitive adenylate cyclase in rat striatal membranes.
    Fleminger S
    Biochem Pharmacol; 1991 Jul; 42(2):229-37. PubMed ID: 1650205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of flupenthixol and flupenthixol-decanoate on methylphenidate and apomorphine-induced compulsive gnawing in mice.
    Christensen AV; Moller Nielsen I
    Psychopharmacologia; 1974 Jan; 34(2):119-26. PubMed ID: 4856369
    [No Abstract]   [Full Text] [Related]  

  • 9. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
    Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers.
    Arnt J; Bøgesø KP; Christensen AV; Hyttel J; Larsen JJ; Svendsen O
    Psychopharmacology (Berl); 1983; 81(3):199-207. PubMed ID: 6139838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
    Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
    Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurotropic properties of fluphenazine].
    Liubimov BI; Raevskiĭ KS; Ostrovskaia RU; Barkov NK; Krolevets GN
    Farmakol Toksikol; 1971; 34(3):287-90. PubMed ID: 5106035
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological properties of new neuroleptic compounds.
    Coscia L; Causa P; Giuliani E; Nunziata A
    Arzneimittelforschung; 1975 Sep; 25(9):1436-42. PubMed ID: 25
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
    Murugaiah K; Fleminger S; Hall MD; Theodorou A; Jenner P; Marsden CD
    Neuropharmacology; 1984 Jun; 23(6):599-609. PubMed ID: 6540376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
    Khisti RT; Deshpande LS; Chopde CT
    Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroleptics. 3. Pharmacology. Introduction.
    Van Rossum JM; Janssen PA; Boissier JR; Julou L; Loew DM; Moller Nielsen I; Munkvad I; Randrup A; Stille G; Tedeschi DH
    Mod Probl Pharmacopsychiatry; 1970; 5():23-32. PubMed ID: 5527165
    [No Abstract]   [Full Text] [Related]  

  • 19. Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat.
    Fleminger S; van de Waterbeemd H; Rupniak NM; Reavill C; Testa B; Jenner P; Marsden CD
    J Pharm Pharmacol; 1983 Jun; 35(6):363-8. PubMed ID: 6135774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analogs of phenothiazines. 6. Stereochemical assignment of isomeric aminoalkylidene derivatives of xanthenes and thioxanthenes with neuropharmacological activity.
    Kaiser C; Warren RJ; Zirkle CL
    J Med Chem; 1974 Jan; 17(1):131-3. PubMed ID: 4808461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.